Press releases
- Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting
- Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
- Evolus Reports First Quarter 2024 Results and Provides Business Update
- Evolus to Report First Quarter Financial Results on May 7, 2024
- Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
- Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
- Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
More ▼
Key statistics
On Friday, Evolus Inc (EVL:STU) closed at 11.50, -19.01% below its 52-week high of 14.20, set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.10 |
---|---|
High | 11.50 |
Low | 11.10 |
Bid | 11.30 |
Offer | 11.70 |
Previous close | 11.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 62.61m |
Free float | 48.93m |
P/E (TTM) | -- |
Market cap | 779.50m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 15 minutes, as of May 24 2024.
More ▼